Search results for: 'Model Based System Engineering market'

Transformative business solutions and customer-centric business models are compressing the value chain. Vertical integration is causing value chain dynamics to change, with new entrants offering end-to-end solutions across the upstream and the downstream stages. The value chain will move from the current product-centric model to consumer-centric da...

25 Jul 2022  |  Global  |  Market Research

US Healthcare Supply Chain Growth Opportunities

New Tracking Software for Inventory Cycle and Risk Management Eases Demand Pressure in Post-Pandemic Environment

Infographics

×

Healthcare supply chain software monitors procurement and distribution data to track inventory and supply within healthcare systems. The healthcare supply chain software vendors in this study offer a range of solutions to providers, such as tracking workflow, monitoring suppliers for risk, and using compiled data to predict future availability of s...

02 Aug 2017  |  North America  |  Megatrends

Future of B2B Online Retailing

Connected Marketplaces Transition from Transactional Hubs to Assistive Selling

Infographics

×

Online B2B retailing is at an inflection point and is going through major shifts in technology and business models. The B2B market will outgrow the B2C market by 2025, with China taking the lead. The market is evolving due to shifts in the impact of mobility and role of digital channels. Retailers, in order to cope up with the change in the market,...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

Static water utility infrastructures are increasingly unable to cope with future demands. Climate change, water scarcity, energy costs, population shifts, budget cuts, and stricter legislation also challenge water services. At the same time, the responsibility of governments to ensure high-quality and accessible water through water and wastewater ...

18 Mar 2021  |  Global  |  Market Research

Digital Twins in the Power and Utilities Industry

Decentralization and Decarbonization Will Drive Adoption across Power Generation, Transmission and Distribution, and Storage and Utilization Segments

Infographics

×

Decentralization, digitization, and decarbonization are transforming the global power and utilities industry. Of these three trends, digitization is the core enabler for decarbonization and decentralization in the industry, disrupting how electricity is produced, stored, distributed, and consumed by end users. Digitization also opens numerous new g...

The ability to visualize and articulate a possible future state for an organization or company has always been a vital component of a companys long term success. Disruption of the global economy, industry, companies and investments make it difficult to prepare your company for the future. A solid, realistic Vision & Strategy will enable you to set ...

This Frost & Sullivan study analyzes Trend Opportunity Profiles that envision the Future of Work from a technology perspective; it covers advanced technologies incorporated in the work culture, and it features upcoming trends that cater to the futuristic needs of the workplace. The study also describes opportunities for several sectors, including b...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...